BioLineRx Ltd Capital Reinvestment Ratio

Latest as of December 2023: 0.00x

BioLineRx Ltd capital reinvestment ratio. BioLineRx Ltd (BLRX) has a Capital Reinvestment Ratio of 0.00x as of December 2023, meaning it reinvests 0% of its operating cash flow ($4.99 Million) in capital expenditures ($18.00K). Check BioLineRx Ltd (BLRX) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

$4.99 Million
USD

Capital Expenditures

$18.00K
USD

Data as of

Dec 2023
Most recent filing

Capital Reinvestment Ratio of BioLineRx Ltd (2010–2010)

Capital reinvestment ratio of BioLineRx Ltd from 2010 to 2010. This chart tracks BioLineRx Ltd's Capital Reinvestment Ratio across 1 annual periods. Also explore BioLineRx Ltd equity growth rate to track the company's year-over-year net asset growth rate.

BioLineRx Ltd Capital Reinvestment Ratio by Year (2010–2010)

BioLineRx Ltd capital reinvestment ratio by year from 2010 to 2010. For the full cash flow conversion analysis, see BLRX operating cash flow.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2010 0.06x $11.46 Million $660.94K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow